Westergren Helena U, Svedlund Sara, Momo Remi A, Blomster Juuso I, Wåhlander Karin, Rehnström Erika, Greasley Peter J, Fritsche-Danielson Regina, Oscarsson Jan, Gan Li-Ming
Department of Molecular and Clinical Medicine, Institute of Medicine, Sahlgrenska Academy at the University of Gothenburg, Gothenburg, Sweden.
Department of Clinical Physiology, Sahlgrenska University Hospital, Gothenburg, Sweden.
Cardiovasc Diabetol. 2016 Feb 19;15:36. doi: 10.1186/s12933-016-0353-1.
Patients with angina-like symptoms without myocardial perfusion scintigram (MPS)-verified abnormality may still be at risk for cardiovascular events. We hypothesized that insulin resistance could play a role in this population even without diagnosed diabetes. We further explored physiological and blood biomarkers, as well as global gene expression patterns that could be closely related to impaired glucose homeostasis to deepen our mechanistic understanding.
A total of 365 non-diabetic patients with suspected myocardial ischemia referred to MPS were enrolled and followed up regarding event-free survival with a median time of 5.1 years. All patients underwent endothelial function assessment by reactive hyperemic index (RHI) using EndoPAT and extensive biomarker analysis. Whole blood global gene expression pathway analysis was performed in a subset of patients.
Homeostasis model assessment of insulin resistance (HOMA-IR) added independent prognostic value in patients without myocardial perfusion defects. In a multivariable analysis, HOMA-IR was inversely associated with low RHI. Furthermore, elevated HOMA-IR was associated with decreased levels of vascular endothelial growth factor D, stem cell factor and endocan as well as to increased level of interleukin-6. Global gene expression pathway analysis of whole blood cells showed that high HOMA-IR and impaired endothelial function were associated with upregulated pro-inflammatory pathways and down-regulated eukaryotic initiation factor-2 pathway.
Insulin resistance measured by HOMA-IR is associated with endothelial dysfunction and confers independent prognostic information in non-diabetic patients with chest pain without myocardial perfusion defects. Increased systemic pro-inflammatory state and decreased levels of pro-angiogenic vascular growth factors may be important underlying molecular mechanisms.
有类似心绞痛症状但心肌灌注闪烁显像(MPS)未证实异常的患者仍有发生心血管事件的风险。我们推测,即使未诊断为糖尿病,胰岛素抵抗在这一人群中也可能起作用。我们进一步探索了可能与葡萄糖稳态受损密切相关的生理和血液生物标志物,以及整体基因表达模式,以加深我们对其机制的理解。
共纳入365例疑似心肌缺血的非糖尿病患者进行MPS检查,并对其无事件生存期进行随访,中位随访时间为5.1年。所有患者均使用EndoPAT通过反应性充血指数(RHI)进行内皮功能评估,并进行广泛的生物标志物分析。对部分患者进行全血整体基因表达通路分析。
胰岛素抵抗的稳态模型评估(HOMA-IR)在无心肌灌注缺损的患者中增加了独立的预后价值。在多变量分析中,HOMA-IR与低RHI呈负相关。此外,HOMA-IR升高与血管内皮生长因子D、干细胞因子和内皮糖蛋白水平降低以及白细胞介素-6水平升高有关。全血细胞的整体基因表达通路分析表明,高HOMA-IR和内皮功能受损与促炎通路上调和真核起始因子-2通路下调有关。
通过HOMA-IR测量的胰岛素抵抗与内皮功能障碍相关,并为无心肌灌注缺损的非糖尿病胸痛患者提供独立的预后信息。全身促炎状态增加和促血管生成血管生长因子水平降低可能是重要的潜在分子机制。